July 14, 2023
January 25, 2025
This week’s newsletter included:
-
FDA Approves ARUP Laboratories’ AAV5 DetectCDx™, a First-Ever Companion Diagnostic Immunoassay for a Gene Therapy
-
IONIQ Is “Best Diagnostic Testing Solution 2023”
-
BD Recognized as a Best Place to Work for Disability Inclusion
-
Recursion Announces Collaboration and $50 Million Investment from NVIDIA
-
Owlet, Inc. Announces NYSE Acceptance of Continued Listing Compliance Plan
-
Late-Breaking KidneyIntelX Evidence Released
-
Matia Mobility Welcomes Karen Roy and Launches Ambassador Program
-
Announcing the 2023 Women Tech Award Finalists
-
The Top 25 CFOs of Utah for 2023
-
Wilson Sonsini Adds Meredith Krannich to Executive Advisory Program
Featured New Member: STRUCK
Recent News
- BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
- Canary Speech Achieves HITRUST e1 Certification for Voice Biomarker Platform
- Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
- Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)
- GE HealthCare’s Economic Impact Across Utah
- RefloDx Wins Trans Atlantic Angel Grand Prize